Teladoc Health gaps down to support level after weak guidance
MarketBeatTeladoc Health stock is down more than 22% after the company delivered a poor outlook for 2024 that has investors questioning future growth prospects
Teladoc Health stock is down more than 22% after the company delivered a poor outlook for 2024 that has investors questioning future growth prospects